share_log

Goldman Sachs Maintains Buy on Calumet Specialty Prods, Lowers Price Target to $17

Goldman Sachs Maintains Buy on Calumet Specialty Prods, Lowers Price Target to $17

高盛維持對Calumet Specialty Prods的買入,將目標股價下調至17美元
Benzinga ·  03/21 08:37

Goldman Sachs analyst Neil Mehta maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Buy and lowers the price target from $19 to $17.

高盛分析師尼爾·梅塔維持Calumet Specialty Prods(納斯達克股票代碼:CLMT)的買入並將目標股價從19美元下調至17美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論